UNIVERSAL TECHNICAL INSTITUTE INC
UTINYSEOther · Services-Educational Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $835.6M | $732.7M | $607.4M | $418.8M | $335.1M | $300.8M |
| Operating income | $83.5M | $58.9M | $21.4M | $22.4M | $14.9M | −$3.9M |
| Net income | $63.0M | $42.0M | $12.3M | $25.8M | $14.6M | $8.0M |
| Total assets | $826.1M | $744.6M | $740.7M | $552.9M | $512.6M | $442.0M |
| Total liabilities | $498.0M | $484.3M | $514.7M | $337.5M | $324.0M | $265.5M |
| Equity | $328.1M | $260.2M | $226.0M | $215.4M | $188.5M | $176.5M |
| EPS (diluted) | $1.13 | $0.75 | $0.13 | $0.38 | $0.17 | $0.05 |
| Shares out. | 54.4M | 54.0M | 34.1M | 33.8M | 32.8M | 32.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 10.0%
- Net margin
- 7.5%
- Return on equity
- 19.2%
- Return on assets
- 7.6%
- Return on capital (ROCE)
- 14.0%
- Liabilities / assets
- 60.3%
- Debt / equity
- 1.52×
- Book value / share
- $6.03
- Revenue growth (YoY)
- 14.0%
- Net income growth (YoY)
- 50.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.91grey zone
- Accruals / assets
- −4.2%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 5 good- Altman Z″ in the grey zone
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 27, 2026
- Coliseum Capital Management, LlcActivist (13D)Dec 5, 2025
- Lord, Abbett & Co. LlcPassive (13G)Aug 14, 2025
- Washington UniversityPassive (13G)Nov 21, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lorenz Tracy KayOfficer — SVP and UTI Division President | May 25, 2026 | Grant | 42,243 | $0.00 |
| Srere Linda JDirector | May 11, 2026 | Sell | 15,000 | $36.59 |
| Kevane Christopher E.Officer — EVP and Chief Legal Officer | Mar 27, 2026 | Sell | 23,654 | $37.55 |
| Brochick George W.Director | Mar 17, 2026 | Sell | 5,000 | $36.59 |
| Okinaka Shannon LeiDirector | Mar 6, 2026 | Sell | 10,000 | $34.74 |
| Okinaka Shannon LeiDirector | Mar 5, 2026 | Grant | 3,565 | $0.00 |
| Slubowski Michael A.Director | Mar 5, 2026 | Grant | 3,565 | $0.00 |
| Brochick George W.Director | Mar 5, 2026 | Grant | 3,565 | $0.00 |
| Hitchcock Todd AOfficer — EVP/COO | Mar 4, 2026 | Sell | 16,500 | $37.33 |
| Smith SherrellOfficer — EVP, Chief Academic Officer | May 12, 2025 | Sell | 50,000 | $33.84 |
| Srere Linda JDirector | Mar 5, 2026 | Grant | 3,565 | $0.00 |
| Sanchez Loretta LydiaDirector | Mar 5, 2026 | Grant | 3,565 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.3M | 3.6 | +16.9% |
| Apr 30, 2026 | 2.8M | 6.6 | -3.5% |
| Apr 15, 2026 | 2.9M | 5.4 | -19.3% |
| Mar 31, 2026 | 3.6M | 5.1 | +3.6% |
| Mar 13, 2026 | 3.5M | 5.0 | +2.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureMay 6, 2026
- Shareholder voteMar 18, 2026
- Item 5.05Mar 17, 2026
- Results of operations · Regulation FD disclosureFeb 4, 2026
- Results of operations · Regulation FD disclosureNov 19, 2025
- Regulation FD disclosureNov 18, 2025
- Results of operations · Regulation FD disclosureAug 6, 2025
- Results of operations · Regulation FD disclosureMay 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.